This article explores current research on GLP-1 medications and joint pain, helping patients and clinicians set appropriate expectations for musculoskeletal outcomes during treatment
This may reflect higher prevalence of obesity-related metabolic comorbidities among men compared to women, which may also be socially patterned [44, 45]
Unlike FDA-approved medicationswhich include GLP-1 receptor agonists (semaglutide, liraglutide) and the dual GIP/GLP-1 receptor agonist tirzepatideprobiotic supplements are classified as dietary supplements under the Dietary Supplement Health and Education Act (DSHEA)
Torre-Aguilar, M
As of June 2025, the branded version of liraglutide, Saxenda, generated $165 million in annual sales alone, and the market for GLP-1s could be set to hit over $126 billion in sales by 2029
Introduction: Fascial plane blocks are an advanced regional anesthesia technique designed to provide effective pain relief by injecting local anesthetic into specific tissue planes